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HsAFP1, a plant defensin isolated from coral bells (Heuchera sanguinea), is
characterized by broad-spectrum antifungal activity. Previous studies indicated that
HsAFP1 binds to specific fungal membrane components, which had hitherto not been
identified, and induces mitochondrial dysfunction and cell membrane permeabilization.
In this study, we show that HsAFP1 reversibly interacts with the membrane phospholipid
phosphatidic acid (PA), which is a precursor for the biosynthesis of other phospholipids,
and to a lesser extent with various phosphatidyl inositol phosphates (PtdInsP’s).
Moreover, via reverse ELISA assays we identified two basic amino acids in HsAFP1,
namely histidine at position 32 and arginine at position 52, as well as the phosphate
group in PA as important features enabling this interaction. Using a HsAFP1 variant,
lacking both amino acids (HsAFP1[H32A][R52A]), we showed that, as compared to
the native peptide, the ability of this variant to bind to PA and PtdInsP’s is reduced
(≥74%) and the antifungal activity of the variant is reduced (≥2-fold), highlighting the
link between PA/PtdInsP binding and antifungal activity. Using fluorescently labelled
HsAFP1 in confocal microscopy and flow cytometry assays, we showed that HsAFP1
accumulates at the cell surface of yeast cells with intact membranes, most notably at
the buds and septa. The resulting HsAFP1-induced membrane permeabilization is likely
to occur after HsAFP1’s internalization. These data provide novel mechanistic insights
in the mode of action of the HsAFP1 plant defensin.
Keywords: plant defensins, yeast, antifungal mode of action, lipid membrane target, peptide internalization,
membrane permeabilization
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INTRODUCTION
Plant defensins are peptides (45–54 amino acids), which are
suggested to be part of the immune system of plants. They
possess a broad-spectrum antimicrobial activity (Carvalho Ade
and Gomes, 2009, 2011; De Coninck et al., 2013), but are in
general non-toxic for plant or human cells (Thevissen et al.,
2007; Tavares et al., 2008; Vriens et al., 2015). Plant defensins
are highly structured peptides that exhibit a common fold
consisting of a cysteine-stabilized αβ-motif (Van der Weerden
and Anderson, 2013) and possess abundant positively charged
and hydrophobic amino acids. In the past decades, the antifungal
mode of action of various plant defensins has been studied
(as reviewed by Vriens et al., 2014). Plant defensins such as
NaD1 (Poon et al., 2014), TPP3 (Baxter et al., 2015) and
MtDef4 (Sagaram et al., 2013), isolated from tobacco, tomato and
barrel clover, respectively, interact with fungal phospholipids,
whereas others such as RsAFP2 (Thevissen et al., 2004), Psd1
(de Medeiros et al., 2010) and DmAMP1 (Thevissen et al.,
2000, 2003), isolated from radish, pea and dahlia, respectively,
interact with fungal-specific sphingolipids like glucosylceramides
and mannosyl diinositolphosphoryl ceramides in the membranes
of susceptible fungi. Upon interaction with their respective
fungal membrane lipid, plant defensins can either be internalized
into the fungal cells, thereby affecting intracellular targets in
the cytosol or nucleus as in case of MtDef4 (Sagaram et al.,
2013), NaD1 (van der Weerden et al., 2010) and Psd1 (Lobo
et al., 2007), or remain on the outside of the fungal cells, as
in case of RsAFP2 (Thevissen et al., 2012). For NaD1 (van
der Weerden et al., 2008), PvD1 (from bean) (Mello et al.,
2011), DmAMP1 (Aerts et al., 2006), HsAFP1 (from coral
bells) (Aerts et al., 2011), Lp-Def1 (from cream nut) (Vieira
et al., 2015) and RsAFP2 (Aerts et al., 2007, 2009) it has
been reported that they subsequently induce the production
of reactive oxygen species (ROS) and/or apoptosis at relatively
low doses, while membrane permeabilization occurs at high
concentrations (Thevissen et al., 1999; Bleackley et al., 2014). The
latter is suggested to be a non-specific secondary effect rather
than the primary cause of microbial killing (Thevissen et al.,
1996).
HsAFP1, a plant defensin isolated from the seeds of coral
bells (Heuchera sanguinea), can inhibit a broad range of fungi,
including the model yeast Saccharomyces cerevisiae and the
most common human pathogen Candida albicans (Osborn
et al., 1995; Thomma et al., 2002; Thevissen et al., 2007). This
peptide is not toxic to human cells (Vriens et al., 2015) and
is characterized by a low in vitro frequency of spontaneous
occurrence of resistance (Thevissen et al., 2007). Moreover, it
can inhibit C. albicans biofilm formation (Vriens et al., 2015),
which points to its potential for further drug development. In
view of the latter, it is important to understand its mechanism
of action, and in particular to identify its fungal interaction
partner(s) and downstream signaling pathways resulting in
fungal growth inhibition. Previously, we have demonstrated that
HsAFP1 interacts with high-affinity binding sites on membranes
of susceptible fungi (Kd = 29 nM) (Thevissen et al., 1997).
This interaction is specific, competitive, reversible and saturable,
pointing to a specific receptor-ligand interaction. However, the
target in the fungal membrane for HsAFP1 remained elusive
as, in contrast to RsAFP2, Psd1 and DmAMP1, fungal-specific
sphingolipids appear not to be involved in HsAFP1’s mode of
action (Aerts et al., 2011).
In the present study, a lipid binding partner of HsAFP1
was identified, after which the domains of both HsAFP1 and
the lipid species involved in this interaction were characterized.
Internalization of HsAFP1 was investigated in S. cerevisiae, as well
as HsAFP1-induced membrane permeabilization resulting in cell
death.
MATERIALS AND METHODS
Strains and Reagents
In this study, the yeast Saccharomyces cerevisiae strain BY4741
and the filamentous fungal pathogen Fusarium culmorum K0311
were used. Yeasts were cultured at 30◦C in YPD (yeast extract
(10 g/L), peptone (20 g/L) and glucose (20 g/L) or YPD/PDB
(potato dextrose broth (19.2 g/L), yeast extract (2 g/L), peptone
(4 g/L) and glucose (4 g/L)) adjusted to pH7 with 50 mM HEPES,
while filamentous fungi were cultured at 22◦C in PDB (12 g/L).
The plant defensins HsAFP1 and HsAFP1[H32A][R52A] were
recombinantly produced in Pichia pastoris and purified using
the protocol described by Vriens et al. (2015). Linear HsAFP1-
derived peptide fragments (HsLin’s) were synthesized and
purified as described previously by Goblyos et al. (2013). Cysteine
residues were replaced by α-aminobutyric acid (α-ABA; X) to
avoid disulphide bond formation in the linear peptides.
All lipids and PIP Strips were purchased from
Echelon (Salt Lake City, UT, United States), except
for dimyristoylphosphatidylcholine (PC), dimyristoyl
phosphatidylglycerol (PG), dimyristoylphosphatidic acid
(PA) used for the DSC experiments and methyl-PA (Avanti
Polar Lipids, Alabaster, AL, United States). rELISA assays
were performed in Nunc-Immuno TM plates Polysorp. Bovine
serum albumin (BSA), NaH2PO4.2H2O and Tween 20 were
used for buffer preparations, while 4-nitrophenyl phosphate
(4-NPP) disodium salt, 5-bromo-4-chloro-3-indolyl-phosphate
(BCIP) and nitro blue tetrazolium (NBT) were used as enzyme
substrates in color reactions for quantification. Antiserum, raised
in rabbits injected with HsAFP1 [as was previously done for
antisera against the plant defensins RsAFP2 and DmAMP1
(Francois et al., 2002)], and anti-rabbit IgG-alkaline phosphatase
were used respectively as primary and secondary antibody. For
HsAFP1 internalization and membrane permeabilization studies,
propidium iodide (PI), 1-ethyl-3-(3-dimethylaminopropyl)
carbodiimide (EDC) and BODIPY-FL-EDA were used.
PIP Strip Overlay Assay for HsAFP1 Lipid
Binding Partner Identification
HsAFP1 lipid binding partners were determined via lipid overlay
assay by using PIP Strips, containing 100 pmol spots of all
phospholipids. The manufacturer’s instructions were adjusted
as follows (i) 1.7 µM HsAFP1 and BCIP/NBT were used
as lipid interaction partner and enzyme (alkaline phosphatase
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(AP)) substrate, respectively, (ii) the enzymatic color reaction
was performed in alkaline phosphate buffer pH9.5 with BCIP
(0.2 g/L) and NBT (0.3 g/L) as substrate and (iii) after 5 min
this reaction was stopped with an EDTA (6 µg/L) solution.
As positive controls, 1 µL of HsAFP1 (16.8 µM) or secondary
antibodies (1/20 diluted) were spotted separately on top of
the PIP Strips (not on the control membrane). When the
spots were dry, the lipid overlay assay was performed as
described above. HsAFP1-lipid binding was determined via pixel
intensity quantification of every spot via Image Studio Lite
software.
Reverse ELISA (rELISA) Assay for
Quantification of HsAFP1 or
HsAFP1[H32A][R52A] Binding
HsAFP1- or HsAFP1[H32A][R52A]-lipid binding was quantified
in a rELISA assay, adapted from the protocol described by
Thevissen et al. (2004). First, the lipid solution (8 µg/mL;
dissolved in methanol) was dried overnight (ON) at room
temperature in Polysorp ELISA plates. All subsequent steps were
performed at 37◦C. After lipid coating, a blocking step with
3% BSA in phosphate-buffered saline (PBS) pH7.4 for 2–3 h
was performed. Next, a two-fold dilution series of HsAFP1
was prepared in 10% blocking buffer (or in 0.2 M – 0.0125
M phosphate buffers for phosphate binding experiments) and
added to the rELISA wells for 1.5 h. Subsequently, the wells
were incubated with primary antibody (1/3000 diluted; 1 h),
secondary antibody (1/3000 diluted; 1 h), and 4-NPP as AP
substrate (1 mg/mL; 10 min). Absorbance at 405 nm was used as
read out. For the rELISA assays, the highest values of the negative
controls, samples without HsAFP1, were used as background
signal and subtracted from the samples. For all competitive
rELISA assays, two-fold dilution series of HsAFP1 in the absence
or presence of a four-fold excess of the competitor (compared
to the highest concentration of HsAFP1) was added to the
rELISA wells in the peptide binding step. In these experiments,
the values of the negative controls, samples with 4x competitor,
were used as background signal. For all rELISA assays, the
% of HsAFP1-lipid binding was calculated relative to the
HsAFP1-PA signal obtained at the highest HsAFP1 concentration
(12.5 µM).
Lipid Vesicles
Two types of vesicles were prepared using following molar ratios
of the phospholipids: PC/PG 75/25 (Payne et al., 2016) and
PC/PG/PA 75/15/10. A total of 20 mg lipid powder was dissolved
in chloroform/methanol 2/1 and subsequently dried as a lipid
film using a rotavap and 3 h of vacuum drying. Next, the lipid
film was dissolved in 2-3 mL of 50 mM HEPES pH7 (Payne et al.,
2016)+ 0.005 M NaCl.
Differential Scanning Calorimetry (DSC)
Thermograms were obtained using a VP-DSC (MicroCal Inc.,
Northampton, MA, United States) device as described by Brand
et al. (2012), except for the scanning rate (0.5◦C/min) and the
peptide concentration (40 µM).
Fluorescent Labeling of HsAFP1 with the
Fluorophore BODIPY
HsAFP1 was fluorescently labeled via its carboxyl groups with the
fluorophore BODIPY-FL-EDA as described by van der Weerden
et al. (2010).
Fungal Growth Inhibition Assay
The antifungal activity of HsAFP1[H32A][R52A] and BODIPY-
HsAFP1 against F. culmorum were determined as described by
Vriens et al. (2015).
Minimum Fungicidal Concentration
(MFC)
Exponentially growing S. cerevisiae cells in YPD were
incubated (OD600 = 1) in PDB/YPD with HsAFP1 or with
HsAFP1[H32A][R52A] for 150 min. Both at the start and at
the end of the treatment, surviving yeast cells were determined
via plating assays. In a plating assay, 10-fold dilution series
of yeast cells in PBS were prepared, after which 100 µL was
plated on YPD plates. After 2 days of incubation at 30◦C,
the number of colony forming units (CFU) was counted and
cell death was calculated relative to time zero (t0). MFC50
values indicating the MFC resulting in 50% cell death, were
determined.
Cell Treatment for Confocal Microscopy
or Flow Cytometry Experiments
Exponentially growing yeast cells in YPD were incubated
(OD600 = 1) in PDB/YPD with HsAFP1 or with BODIPY-
HsAFP1 (B-Hs; 4 – 48 µM), propidium iodide (PI) (2 µg/mL)
for 150 min (endpoint) unless stated otherwise. In parallel to
confocal microscopy or flow cytometry experiments, plating
assays were performed to determine MFC50 values, as described
above.
Confocal Microscopy of Saccharomyces
cerevisiae Cells Treated with
BODIPY-HsAFP1
HsAFP1 localization studies were performed on yeast cells treated
with BODIPY-HsAFP1 (4, 16, or 48 µM) and PI (2 µg/mL)
as described above. After 60–150 min of treatment, cells were
visualized by confocal microscopy with the FluoView FV1000
confocal microscope (Olympus IX81) and its software. We used
a 60x magnification objective and 1-6x computer zoom. The
488 nm laser line of the Argon laser was used for visualization
of BODIPY and the 559 nm laser for PI. To ensure that there
is no spectral overlap between the green and red channel of
our microscope, we examined fluorescence of BODIPY-HsAFP1
and PI in both channels and only observed a fluorescent signal
for BODIPY-HsAFP1 in the green channel and a fluorescent
signal for PI in the red channel and not vice versa. Hence, no
cross-talk between the channels was found in our experimental
setup.
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Flow Cytometry of Saccharomyces
cerevisiae Cells Treated with
BODIPY-HsAFP1
HsAFP1 uptake and HsAFP1-mediated membrane
permeabilization in yeast cells were determined via flow
cytometric analysis. Yeast cells were treated with BODIPY-
HsAFP1 (B-Hs) and PI, as described above, and subjected to
flow cytometry on a BD InfluxTM cell sorter. Approximately
10,000 cells were monitored for fluorescence at 530/40 nm
(FL2_λex = 488 nm) and 610/20 nm (FL11_ λex = 561 nm)
for the detection of BODIPY-HsAFP1 uptake (B-Hs+) and
membrane permeabilization (PI+), respectively. Data from
cells treated with MQ were used as background signal. For the
kinetic experiments in Figure 8, the cell cultures were divided
in 4 subpopulations (B-Hs-/PI-, B-Hs+/PI-, B-Hs-/PI+ and
B-Hs+/PI+) based on the fluorescence intensities of the control
(MQ) treatment, which was B-Hs-/PI-.
Data Analysis
Data were analyzed with GraphPad Prism 6 and mean± standard
error of mean (SEM) were represented for n ≥ 2 experiments.
We assumed that all data are normally distributed. To analyze
significant differences between the reference HsAFP1-PA binding
(at 12.5 µM HsAFP1) and HsAFP1 bindings in other conditions,
unpaired student t-test with Welch’s correction (if only two
conditions were compared) or one-way ANOVA followed by
Dunnett multiple comparison (if more than two conditions
were compared) was performed. ∗, ∗∗, ∗∗∗ and ∗∗∗∗ represent
P < 0.05, P < 0.01, P < 0.001 and P < 0.0001, respectively.
Data of the thermal scans (DSC experiments) were normalized
for the vesicle concentration, baseline subtracted (linear connect)
and subsequently fitted with a non-two state model using
the MicroCal OriginTM software. To determine significant
differences between MIC50 values of native and BODIPY-
labeled HsAFP1, an unpaired student t-tests was used. Flow
cytometric data were presented as means ± SEM of the
% of (BODIPY-HsAFP1 or PI) positive cells relative to the
whole cell population. One-way ANOVA with Dunnett multiple
comparison was used to determine significant differences in
the size of the subpopulations compared to those at the lowest
BODIPY-HsAFP1 concentration or time zero.
RESULTS
HsAFP1 Interacts with Phospholipids
We assessed potential binding between HsAFP1 and specific
lipids using PIP Strips, containing phosphoinositides and other
biologically important lipids. HsAFP1 bound to PA and several
phosphatidylinositol phosphate (PtdInsP)-derivatives, including
PtdIns(3)P, PtdIns(4)P, PtdIns(5)P, PtdIns(3,4)P2, PtdIns(3,5)P2,
PtdIns(4,5)P2 and PtdIns(3,4,5)P3 (Figures 1A,B). This was
further confirmed using reverse ELISA (rELISA), in which
lipids are immobilized to the wells of microtiter plates and
bound HsAFP1 is detected immunologically. This type of ELISA
was previously used to characterize the binding of RsAFP2
to fungal glucosylceramides (GlcCer) (Thevissen et al., 2004).
Using rELISA assays, we assessed HsAFP1 binding to the above
indicated lipid species, except for PtdIns(3,4)P2. Consistent with
the PIP Strip overlay assay, HsAFP1 bound to PA (orange bar in
Figure 1C) as well as to several PtdInsP-derivatives containing
at least one phosphate (P) group (red bars in Figure 1C).
However, binding of HsAFP1 to PA was most pronounced
and therefore further investigated. The PIP Strip and rELISA
data on HsAFP1-PA interactions were further confirmed using
lipid vesicles. Using Differential Scanning Calorimetry (DSC),
the thermotropic behavior of these vesicles in the absence and
presence of HsAFP1 was determined. Using a non-two state
fitting model, two phase transition temperatures (Tm1 and
Tm2) were determined. Shifts in Tm values are indicative for
membrane interactions. We observed small Tm1 and Tm2 shifts
(ranging between 0.3 and 0.4◦C) for the phosphatidylcholine
(PC)/phosphatidylglycerol (PG) (75/25) vesicles upon addition
of HsAFP1, while the Tm1 and Tm2 shifts (ranging between
1.0 and 1.6◦C) were larger in case of the PA-containing
PC/PG/PA (75/15/10) vesicles (Figure 1D). Together, these
results point to a HsAFP1-PA interaction in non-membrane (as
in the rELISA assays) as well as in membrane (lipid bilayer)
conditions.
HsAFP1 Interacts with the Phosphate
Group of Phosphatidic Acid via Its Most
C-terminal Arginine
To identify the HsAFP1 domain responsible for the binding
to PA, we tested competition for PA binding between HsAFP1
and different linear 24-mer HsAFP1-derived peptide fragments
spanning the entire HsAFP1 sequence (HsLin01-06; Figure 2).
HsAFP1 was co-incubated with an excess of these linear HsAFP1-
derived fragments and the amount of HsAFP1 bound to PA in
the presence of the linear fragments was quantified via rELISA.
As the HsAFP1 antiserum interacted to a limited extent with
various HsLin peptides, these background values were subtracted
from the corresponding data. We found that only HsLin06
(P < 0.0001) significantly reduced the binding of HsAFP1 to
PA, indicating that the C-terminal part of HsAFP1 is important
for PA binding (orange bar in Figure 3A). Additionally, we
performed a sequential competitive rELISA in which HsAFP1
was incubated with PA for 30 min prior to the addition of
an excess of HsLin06, allowing HsAFP1 to bind to PA first.
We found that bound HsAFP1 could be expelled by excess
of HsLin06 (Supplementary Figure S1) and this to a similar
extent as in a simultaneous rELISA assay (Figure 3A), indicating
that the binding of HsAFP1 to PA is reversible. To further
identify the domains of HsLin06 important for PA binding,
we assessed competition for PA binding between HsAFP1 and
HsLin06 variants that were incrementally shortened at their
N-terminus (HsLin06_01;03;06;10;15; Figure 2) or C-terminus
(HsLin06_02;05;09; Figure 2). Only C-terminally shortened
HsLin06 variants 02 (P = 0.0002) and 05 (P = 0.0002) could
compete with HsAFP1 for PA binding, and this to the same
extent as HsLin06 (around 75–80%; orange bars in Figure 3B),
while variant HsLin06_09 could not compete at all (P = 0.9998;
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FIGURE 1 | Lipid interaction partners of HsAFP1 determined via (A,B) protein-lipid overlay assay using PIP Strips, (C) rELISA and (D) phospholipid vesicles. (A) The
PIP Strips were incubated with HsAFP1 (lower membrane) or without HsAFP1 (top control membrane) and subsequently with HsAFP1 antiserum, anti-rabbit
IgG-Alkaline Phosphatase and 4-nitrophenyl phosphate. Colored spots represent HsAFP1 binding events, as indicated by black arrows (A), which were quantified
via Image Studio Lite (B). (C) Optical density (OD405 nm) values representing the interaction of 12.5 µM HsAFP1 with the control (MeOH) and all tested
phospholipids. Data are means ± SEM, for n ≥ 3 experiments. Significant differences between HsAFP1-MeOH and HsAFP1-lipid interactions were determined via
one-way ANOVA followed by Dunnett multiple comparison, with ∗∗∗ and ∗∗∗∗ representing P < 0.001 and P < 0.0001, respectively. (D) Thermograms of
phosphatidylcholine(PC)/phosphatidylglycerol(PG) (75/25) and PC/PG/phosphatidic acid(PA) (75/15/10) vesicles in absence or presence of HsAFP1, as determined
via DSC experiments. Representative graphs of the phase transition of 0.5 mM liposomes in absence or presence of 40 µM HsAFP1 are presented in black, with the
corresponding fit (using a non-two state model) shown in red. Both the fit of the two peaks as well as the overall fit were presented in red. Phase transition
temperatures of both peaks of the fit (Tm1 and Tm2) ± SD are specified in the box.
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FIGURE 2 | Amino acid sequence alignment of HsAFP1 with HsAFP1 mutant HsAFP1[H32A][R52A], HsAFP1-derived peptide fragments (HsLin01-HsLin06),
HsLin06-derived peptide fragments (HsLin06_02;05;09;01;03;06;10 and 15) and the plant defensins NsD7, MtDef4 and NaD2. Gray bars indicate the highly
conserved amino acids among plant defensins. The blue, green, and the orange boxes represent the position of the PA binding domain, the amino acid substitutions
and the γ-core, respectively. (-) denote gaps in the alignment.
FIGURE 3 | Amino acids of HsAFP1 important for phosphatidic acid (PA) binding, using competitive rELISA assays. Competition of 12.5 µM HsAFP1 with 50 µM
HsLin01-06 (A), C-truncated HsLin06 variants (HsLin06_02;05;09 in Figure 2; (B) or N-truncated variants (HsLin06_01;03;06;10;15 in Figure 2; (C) with both
peptides co-incubated. Data are means ± SEM, for n ≥ 3 experiments. Data are expressed relative to the HsAFP1-PA binding without HsLin. Significant differences
between HsAFP1 and HsAFP1 + 4x HsLin interactions were determined via one-way ANOVA followed by Dunnett multiple comparison, with ∗, ∗∗∗, and ∗∗∗∗
representing P < 0.05, P < 0.001, and P < 0.0001, respectively. (D) 3D structure of HsAFP1 with the positively charged amino acids [histidine (H) 32 and 40, lysine
(K) 47, K51 and arginine (R) 52] of HsLin06 drawn in blue on its backbone, using the Chimera visualization program. Green clustered amino acids (H32 and R52) are
important for PA binding while the red clustered (H40, K47 and K51) are not.
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gray bar Figure 3B). Since HsLin06_02 and 05 differ from
HsLin06_09 only in their C-terminal arginine (R, position 52
in HsAFP1), these data show that R52 is an important amino
acid for PA binding. Of the HsLin06 variants shortened at their
N-terminus, only HsLin06_01 (P < 0.0001) could compete with
HsAFP1 for PA binding, and this to the same extent as HsLin06
(around 75–80%; orange bars Figure 3C), while all other variants
(HsLin06_06;10;15) could only partially (around 35%; red bars in
Figure 3C) do so (with P = 0.0229, P = 0.0024 and P = 0.0003,
respectively). Hence, it seems that the N-terminal histidine of
HsLin06 (H, position 32 in HsAFP1) is important, but not
essential for PA binding as HsLin06 variants 03; 06; 10 and 15,
which are all lacking this amino acid, can still partially compete
with HsAFP1 for PA binding. To confirm the important role
of H32 and R52 for HsAFP1’s PA binding action, a HsAFP1
mutant peptide in which both H32 and R52 were replaced by
alanine (A) was produced (HsAFP1[H32A][R52A] (Figure 2))
and subsequently tested for PA binding and antifungal activity.
Binding of HsAFP1[H32A][R52A] to PA was reduced by 77%
as compared to native HsAFP1 (Figure 4A). Also binding of
HsAFP1[32A][R52A] to PtdIns(3,5)P2 and PtdIns(4,5)P2 was
significantly reduced compared to native peptide (Figure 4A).
Next, the MIC50 (minimum inhibitory concentration resulting
in 50% cell growth reduction) on F. culmorum and the
MFC50 (MFC resulting in 50% cell death) on S. cerevisiae
were determined for HsAFP1[H32A][R52A] and native HsAFP1.
Compared to the native peptide, the MIC50 and the MFC50
of HsAFP1[H32A][R52A] were 3.5-fold and 2-fold higher
(Figure 4B), respectively, demonstrating reduced antifungal
activity as well as reduced phospholipid (PA/PtdIns) binding for
HsAFP1[H32A][R52A].
Next, we investigated structural requirements of PA enabling
HsAFP1 binding, focusing on the phosphate group in PA.
We investigated the binding of HsAFP1 to methyl-PA in
which the hydroxyl group of the phosphate group of PA
is methylated, resulting in a changed ionization state of PA
and in a less accessible phosphate group. Binding of HsAFP1
to methyl-PA was significantly reduced as compared to PA
(Figure 5A; P = 0.0046), indicating that a free phosphate group
in PA is important for HsAFP1 binding. Next, we assessed
binding of HsAFP1 to PA in buffers with different phosphate
concentrations. The higher the phosphate concentration of the
buffer, the lower the amount HsAFP1 bound to PA was measured
(Figure 5B). This result indicates competition between PA
and free phosphates for HsAFP1 binding. Together, these data
point to the phosphate group in PA as the HsAFP1 binding
feature.
HsAFP1 Is Accumulating at the Yeast
Cell Surface and Induces Membrane
Permeabilization
Given HsAFP1’s capacity to bind membrane phospholipids,
we investigated potential membrane-dependent localization of
HsAFP1 in yeast cells. To this end, we labeled HsAFP1 with the
green fluorescent marker BODIPY, as previously described for
NaD1 (van der Weerden et al., 2010) and confirmed that the label
did not affect the antifungal activity of HsAFP1 nor its PA binding
(Supplementary Figure S2).
At high (10x HsAFP1’s MFC50; 48 µM) BODIPY-HsAFP1
doses and normal laser intensities (Figure 6A), most yeast cells
accumulated BODIPY-HsAFP1 intracellularly after 150 min of
incubation, pointing to HsAFP1 uptake. To assess whether the
latter is a result of HsAFP1-induced membrane permeabilization,
which was reported at high HsAFP1 doses (>8.4 µM under
different experimental conditions) (Thevissen et al., 1999), we
simultaneously assessed membrane permeabilization via (red
fluorescent) PI (Riccardi and Nicoletti, 2006) and found that the
yeast cells that accumulated BODIPY-HsAFP1 intracellularly had
permeabilized membranes (BODIPY-HsAFP1+/PI+). However,
some cells (<1% of the BODIPY-HsAFP1 + population, as
measured via flow cytometric analysis) showed intracellular
HsAFP1 accumulation and intact membranes (BODIPY-
HsAFP1+/PI-; as indicated by arrows in Supplementary
Figure S3). Additionally, at higher laser intensities, a second
subpopulation of BODIPY-HsAFP1+/PI- cells were apparent
that accumulated BODIPY-HsAFP1 on their cell surface and
had intact membranes (as indicated by arrows in Figure 6B). At
this laser intensity no autofluorescence of the cells was visible
(data not shown). Hence, at 48 µM BODIPY-HsAFP1, there
seem to be two distinct subpopulations with intact membranes
that either accumulate BODIPY-HsAFP1 on their surface
(which are characterized by low intensity green fluorescence
and hence, only apparent when using high laser intensity) or
accumulate BODIPY-HsAFP1 intracellularly (characterized by
higher intensity green fluorescence and hence, apparent when
using normal laser intensity).
To get more insight in BODIPY-HsAFP1’s localization, being
at the cell surface and/or intracellularly, we performed additional
confocal microscopy using an intermediate BODIPY-HsAFP1
dose (16 µM) and shorter treatment time (60 min). At normal
laser intensities, only cells with intense green fluorescence
signal were apparent (Figure 7A). These cells had permeabilized
membranes and the BODIPY-HsAFP1 signal was intracellularly
located. Additionally, at higher laser intensities, a subpopulation
of PI- cells with BODIPY-HsAFP1 located at the cell surface,
mainly at the buds and septa (as indicated by the arrows in
Figure 7B) was apparent.
To quantify the different BODIPY-HsAFP1/PI populations
over time in treated yeast cultures, we used flow cytometry
(Figure 8). Treatment of yeast cultures with 48 µM
BODIPY-HsAFP1 resulted in the appearance of a B-Hs+/PI−
subpopulation after 15 min (14% of the treated culture), whereas
a B-Hs+/PI+ subpopulation was apparent after 30 min (9% of
the treated culture; P = 0.0007). Note that the B-Hs+ population
might consist of cells that accumulate BODIPY-HsAFP1 on
their surfaces and/or cells that accumulate BODIPY-HsAFP1
intracellularly. Treatment of yeast cultures with a low BODIPY-
HsAFP1 concentration (4 µM) resulted in the appearance of
a BODIPY-HsAFP1 (B-Hs)+/PI− subpopulation after 30 min
(P= 0.0228), whereas a B-Hs+/PI+ subpopulation was apparent
after 150 min (22% of the treated culture; P > 0.0001).
Together, the flow cytometry data showed that treatment of a
yeast culture with BODIPY-HsAFP1 results first in accumulation
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FIGURE 4 | Reduced phospholipid binding capacity (A) and antifungal activity (B) of HsAFP1[H32A][R52A] compared to native HsAFP1. Data are means ± SEM, for
n ≥ 3 experiments. (A) Optical density (OD405 nm) values representing the interaction of 12.5 µM HsAFP1 or HsAFP1[H32A][R52A] with all phospholipids tested
[phosphatidic acid (PA), phosphatidylinositol(3,5)bisphosphate (PtdIns(3,5)P2), phosphatidylinositol(4,5)bisphosphate (PtdIns(4,5)P2)], determined via rELISA assays.
Significant differences between HsAFP1 and HsAFP1[H32A][R52A] were determined via two-way ANOVA followed by Sidak multiple comparison, with ∗∗∗ and ∗∗∗∗
representing P < 0.001 and P < 0.0001, respectively. (B) Minimum Inhibitory Concentration of HsAFP1 or HsAFP1[H32A][R52A] resulting in 50% cell growth
reduction (MIC50) of F. culmorum and Minimum Fungicidal Concentration of HsAFP1 or HsAFP1[H32A][R52A] resulting in 50% cell death (MFC50) of S. cerevisiae.
Significant differences between HsAFP1 and HsAFP1[H32A][R52A] were determined via an unpaired student t-test with Welch’s correction, with ∗ representing
P < 0.05.
of BODIPY-HsAFP1 at the cell surface and/or intracellularly
(B-Hs+), after which membrane permeabilization occurs (PI+).
Microscopic analysis indicated that BODIPY-HsAFP1 primarily
associates with buds and septa, without affecting membrane
integrity.
DISCUSSION
Similar as for some other plant defensins, we showed that
HsAFP1 interacts with various lipids using lipid overlay assays
(PIP Strips) (Sagaram et al., 2013; Baxter et al., 2015; Payne et al.,
2016) as well as rELISA assays (Thevissen et al., 2004). Using PIP
Strips, PtdIns(3,4,5)P3 was identified as the strongest interaction
partner of HsAFP1 followed by PtdIns(3,4)P2. As PtdIns(3,4,5)P3
and PI(3,4)P2 are not present in yeast (Vanhaesebroeck et al.,
2001), PA seems the main HsAFP1-interactor. These results
were further confirmed in a more quantitative assay (rELISA
setup), also indicating PA as the strongest of the potential
interaction partners of HsAFP1 tested. As both assays can give
an indication of lipid specificity but lack biological environment,
we additionally tested HsAFP1-PA interactions in a membrane
context. We showed that HsAFP1 specifically interacted with
vesicles containing PA. However, as these interactions could only
be observed when using low salt concentrations, this interaction
is presumably mediated via electrostatic binding. Moreover, as
the area under the melting curve did not change by HsAFP1
addition, this interaction seems superficial. In addition, using
rELISA assays, we demonstrated that HsAFP1 reversibly binds to
PA, which is consistent with our previous findings on HsAFP1-
membrane target interactions (Thevissen et al., 1997). We further
identified the region in HsAFP1 responsible for PA binding
via rELISA assays in which competition between HsAFP1 and
HsAFP1-derived peptide fragments for PA binding was assessed.
We found that the C-terminal domain of HsAFP1 (HsLin06) can
prevent binding of HsAFP1 to PA, indicating that this domain
in HsAFP1 mediates PA binding. Moreover, the arginine (R) at
position 52 in HsAFP1 seems essential for PA binding, while
the histidine (H) at position 32 in HsAFP1 seems favorable, but
not essential for PA binding. Both amino acids are located in
close proximity of each other on the HsAFP1 structure (green
cluster in Figure 3D). The other positively charged amino acids
in the C-terminal part of HsAFP1 (H40, lysine (K) 47 and K51),
which seem not important for PA binding, are differently located
(red cluster in Figure 3D). This is in line with reports of other
proteins that bind to PA, such as mTOR, in which multiple amino
acids contribute to PA docking, with an arginine being necessary
for this interaction (Veverka et al., 2008). Hitherto, three other
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FIGURE 5 | Phosphate-dependent binding of HsAFP1 to phosphatidic acid (PA), determined via rELISA assays. Interaction of 12.5 µM HsAFP1 with PA or
methyl-PA (A) or for the interaction of HsAFP1 with PA in buffers with different phosphate concentrations (B). Data are means ± SEM, for n ≥ 3 experiments. Data
are expressed relative to the HsAFP1-PA binding (A) or relative to the HsAFP1-PA binding in demi-water (0 M NaH2PO4) (dotted line) (B). Significant differences
between PA and methyl-PA interactions were determined via an unpaired student t-test with Welch’s correction (A), while significant differences between demi-water
(0M NaH2PO4) and phosphate buffers were determined via one-way ANOVA followed by Dunnett multiple comparison (B), with ∗∗ and ∗∗∗ representing P < 0.01
and P < 0.001, respectively.
FIGURE 6 | HsAFP1 localization in S. cerevisiae cells treated with high (48 µM) BODIPY-HsAFP1 concentrations. Confocal microscope images of 150 min-treated
S. cerevisiae cultures with 48 µM BODIPY-HsAFP1. Propidium iodide (PI; 2 µg/mL) was used to identify membrane permeabilization. (A) Confocal images acquired
with normal laser intensities [Alexa fluor 488-10% (argon laser)-HV451 and PI-1% (559nm laser)-HV405]. (B) Confocal images taken at high laser intensities [Alexa
fluor 488-10% (argon laser)-HV573 and PI-1% (559 nm laser)-HV566], without impacting autofluorescence. Representative BODIPY-HsAFP1+/PI- cells are indicated
with arrows. Bar: 5 µm.
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FIGURE 7 | BODIPY-HsAFP1 is located intracellularly in membrane-permeabilized cells and at the cell surface of non-membrane permeabilized S. cerevisiae cells
treated with 16 µM BODIPY-HsAFP1. Confocal microscope images of 60 min treated S. cerevisiae cultures with 16 µM BODIPY-HsAFP1. Propidium iodide (PI;
2 µg/mL) was used to identify membrane permeabilization. (A) Confocal images acquired with normal laser intensities (Alexa fluor 488-10% (argon laser)-HV573 and
PI-1% (559 nm laser)-HV600). (B) Confocal images taken at high laser intensities [Alexa fluor 488-10% (argon laser)-HV700 and PI-1% (559 nm laser)-HV600],
without impacting autofluorescence. Representative BODIPY-HsAFP1 accumulation spots at the cell surface are indicated with arrows. Bar: 5 µm.
FIGURE 8 | Kinetics of HsAFP1 internalization and membrane permeabilization in S. cerevisiae treated with (A) low (4 µM) or (B) high (48 µM) BODIPY-HsAFP1
(B-Hs) and 2 µg/mL propidium iodide (PI), determined via flow cytometry. The gray dashed line represents the percentage of B-Hs+ yeast cells in the population,
relative to control (MQ water) treatment, which can be further divided in two subpopulations: yeast cells with (PI+; orange squares) and without (PI–; black circles)
compromised membranes. Data are means ± SEM, for n = 3 experiments. To analyze significant differences in the size of the subpopulations between the time zero
and other time points, one-way ANOVA followed by Dunnett multiple comparison was performed.
plant defensins that interact with PA have been identified, namely
NsD7 (Kvansakul et al., 2016), MtDef4 (Sagaram et al., 2013) and
NaD2 (Payne et al., 2016). However, neither primary sequence
homology nor structural alignments were found between the
PA-interacting RGFRRR region (located in the γ-core) in MtDef4
(Sagaram et al., 2013), which is also present in NaD2 (Payne
et al., 2016), and the corresponding region in HsAFP1 or NsD7
(Figure 2). A common feature of the PA binding region of
HsAFP1, NsD7, MtDef4 and NaD2 is the presence of positively
charged amino acids. This is in line with previous reports on the
amino acid sequences of various PA effectors that indicated that
there is no defined PA binding sequence, and only the presence
of both positively charged amino acids and hydrophobic amino
acids can enable PA binding in lipid environments (Stace and
Ktistakis, 2006; Shin and Loewen, 2011).
Since the phosphomonoester (phosphate) head group of
PA is negatively charged and therefore mainly responsible for
electrostatic interactions with basic amino acid residues of PA
effector proteins, we examined HsAFP1 interaction with methyl-
PA, which bears a methyl-group substitution on the phosphate
moiety (Young et al., 2010), making the latter less negatively
charged and less available for binding. As expected, this resulted
in a reduction of HsAFP1 binding by more than 75%. Moreover,
besides the interaction of HsAFP1 with the phosphate group
of PA, we demonstrated that free phosphates in the buffer can
compete with PA for HsAFP1 binding, pointing to phosphate-
HsAFP1 interactions.
Besides PA, HsAFP1 also bound to various other
phospholipids, as was previously shown for MsDef1, MtDef4,
NaD1 and NaD2 (Sagaram et al., 2013; Baxter et al., 2015;
Payne et al., 2016). Moreover, we demonstrated for the
HsAFP1[H32A][R52A] double mutant that H32 and R52 are
important for PtdInsP binding as well. This is not surprising
as different PA effectors have also been shown to bind to other
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lipids, such as PtdInsP’s (Testerink and Munnik, 2011). In case
of HsAFP1, it seems that the phosphate group(s) present in
PA and all PtdInsP’s, enable(s) interactions with HsAFP1, since
lipids containing at least one phosphate group were identified
as HsAFP1 interaction partners in the PIP Strip overlay assays.
Why HsAFP1 binds preferentially with PA in the rELISA assays
has to be elucidated further. As shown for the PA-interacting
plant defensin NsD7 (Kvansakul et al., 2016), it might be that
HsAFP1’s PA-binding site contains a small pockets size that can
only accommodate a single phosphate group, which makes it
selective for PA. Consistent with our data, it has been reported
that NaD1 interacts with phosphate groups of PtdIns(4,5)P2.
This leads to oligomerization of NaD1:PtdIns(4,5)P2 complexes
(Poon et al., 2014), which was recently found not essential for the
antifungal activity of NaD1 (Bleackley et al., 2016).
Most importantly, using the HsAFP1[H32A][R52A] double
mutant, we showed that phospholipid (PA and PtdInsP’s)
interacting capacity of HsAFP1 is important for its antifungal
activity. Based on our microscopic and flow cytometry analyses,
we propose a 3-step killing process of the plant defensin
HsAFP1 in S. cerevisiae. Firstly, HsAFP1 accumulates in low
amounts at the yeast cell surface and this accumulation is most
pronounced at the buds and septa. It has been shown that
PtdIns(4,5)P2 is enriched in septa, as this phospholipid is the
main regulator of cytokinesis (Brill et al., 2011). Next, HsAFP1
is internalized in yeast cells, immediately followed by membrane
permeabilization as only a very small subpopulation (<1%)
of HsAFP1-treated yeast cells exist that show internalization
of HsAFP1 with intact membranes. After permeabilization,
additional BODIPY-HsAFP1 might diffuse further into the cells,
resulting in cells with a very intense green fluorescence signal,
as was apparent in microscopy performed at high BODIPY-
HsAFP1 doses after 150 min of incubation. We previously
demonstrated that HsAFP1 treatment of a yeast culture results
in a subpopulation of apoptotic cells (i.e., dead cells that are
PI-) (Aerts et al., 2011). In the current study, on average 10%
of the HsAFP1-treated cultures was found dead, as determined
via plating assays (data not shown), while being PI- (based
on the corresponding flow cytometry analysis of the cultures).
Whether these apoptotic cells internalized HsAFP1 is not clear.
Hence, future work in our laboratory will be directed to the
use of a systems biology approach to investigate the kinetics
of BODIPY-HsAFP1 internalization and cell death, thereby also
focusing on yeast apoptosis, using single cell digital microfluidics
(DMF).
Similar to HsAFP1, peptide accumulation on the cell
surface prior to membrane permeabilization and cell entry
has been demonstrated for the plant defensin NaD1 (Hayes
et al., 2013). As HsAFP1 internalization is probably not
resulting from the HsAFP1-induced membrane permeabilization
in S. cerevisiae, peptide translocation across cell membranes
independent of membrane permeabilization should be part
of HsAFP1 killing mechanism. Pore-independent peptide
translocation has been reported for some antimicrobial peptides
(AMPs) and is thought to be mediated by either endocytic or
physical (spontaneous protein-membrane interaction) processes.
Henriques and colleagues suggested that depending on the
circumstances (such as peptide concentration and temperature),
AMPs can be internalized via both routes (Henriques et al.,
2006). We found that HsAFP1’s internalization is at least partially
mediated by endocytosis as it was significantly reduced in a yeast
mutant that is affected in endocytosis (1end3) (Raths et al., 1993)
(data not shown).
CONCLUSION
We showed that HsAFP1 can bind to various lipids which contain
at least one phosphate group, with PA being the lipid binding
partner resulting in the most pronounced HsAFP1 binding. We
identified two basic amino acids in HsAFP1, the histidine at
position 32 and arginine at position 52, as well as the phosphate
group in PA as important features enabling this interaction.
Hence, we can conclude that the RGFRRR region, present in the
PA-interacting plant defensins MtDef4 and NaD2 and previously
defined as the region important for PA binding and cell entry,
is not the only domain enabling PA binding of plant defensins,
as this region is not present in HsAFP1. Moreover, we showed
that HsAFP1 is accumulating at the yeast cell surface, primarily
in buds and septa, which results in membrane permeabilization,
potentially upon internalization of the peptide.
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